Last Updated on January 10, 2025 by The Health Master
Jan Vishwas Act
The Federation of Pharmaceutical Entrepreneurs (FOPE) has raised an important issue with the Union government regarding the issuance of the final notification for the Jan Vishwas Act.
This landmark legislation was introduced to simplify the various regulatory processes and create a positive environment for the pharmaceutical sector in India.
Compounding the Offence
The draft rules, notified via notification No. GSR 374(E) dated 10-07-2024 for framework for compounding minor offences under the Drugs and Cosmetics Act 1940 (D&C Act).
The core objective of the Jan Vishwas Act is to decriminalize minor offenses and promote a trust-based governance model.
Benefits of the Notification
Regulatory Burden:
It will streamline the compounding process and reduce the regulatory burden on the pharmaceutical sector, which will allow them to focus on patent care and further innovation.
Transparency and consistency:
The Jan Vishwas Act gives power to create a dedicated compounding authority and its reporting mechanism, which will ensure transparency and consistency in the handling of offences.
Ease of Doing Business
A clear and transparent regulatory framework will improve the ease of doing business for pharmaceutical companies in India.
FOPE’s Role in favour of Pharma industry
FOPE has played a very important and crucial role as a bridge between the pharma companies and drug regulatory authorities.
FOPE has been instrumental in a collaborative and productive relationship between the two by actively raising the various issues related to the pharma industry.
Jan Vishwas Act: Key Provisions
Designated Compounding Authority:
The Act gives a mandate establishing a dedicated compounding authority with designated officials to decide the matters on request for compounding the offences.
Reporting process:
A robust mechanism of reporting will ensure monitoring and the proper documentation of the compounding process.
Application Process:
A standardized application form with the process will be introduced to streamline the process for individuals and companies who wish to seek compounding of offences.
In conclusion, FOPE strongly believes that the early issuance of the final notification for the Jan Vishwas Act is very important and crucial for the development and growth of the pharmaceutical industry in India.
1. What is the Jan Vishwas Act?
The Jan Vishwas Act is landmark legislation and the core objective of the Jan Vishwas Act is to decriminalize minor offenses and promote a trust-based governance model across various sectors, including the pharmaceutical industry.
2. What are the key benefits of the Jan Vishwas Act for the pharmaceutical industry?
It will streamline the compounding process and reduce the regulatory burden on the pharmaceutical sector, which will allow them to focus on patent care and further innovation.
3. What are the key provisions of the Jan Vishwas Act related to offence compounding?
1. The Act gives a mandate establishing a dedicated compounding authority with designated officials to decide the matters on request for compounding the offences.
2. A robust mechanism of reporting will ensure monitoring and the proper documentation of the compounding process.
3. A standardized application form with the process will be introduced to streamline the process for individuals and companies who wish to seek compounding of offences.
Disclaimer: This article is for informational purposes only and should not be considered legal or professional advice.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Ease of living and doing business by providing compounding of offences: D&C Act
PCI frames new Regulations in accordance with Jan Vishwas Act
Compounding Of Offence Under Jan Vishwas Act
Altered Provisions: Jan Vishwas (Provisions Amendment) Act, 2023
Decoding the Jan Vishwas Act on penalties for NSQ drug offenses
Pulse Oximeters: Different reading in people of different colors
PCI: Relaxation in Exit Examination for Pharmacists
CDSCO: Sub-Zonal Office established in Bhubaneswar
Updating the classification of Medical Devices: Draft
Key Notes on Revised Schedule M: Topical Products (External Preparations)
Ease of living and doing business by providing compounding of offences: D&C Act
Fire at Pharma Plant of RPG Life Sciences: Mumbai
Key Notes on Revised Schedule M: Oral Liquids
Extension the deadline for Revised Schedule M: Draft notification
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
